High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105354 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Daniela Cabibi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Ita…. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase Inhibitor p16, Immunohistochemistry, Papillomavirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union - NextGenerationEU through the Italian Ministry of University and Research under PNRR -M4C2-I1.3 Project PE_00000019 "HEAL ITALIA" to Prof. Dani…, European Union.
Abstract (Originalsprache)
In cervical biopsies, for diagnosis of Human Papilloma Virus (HPV) related conditions, the immunohistochemical staining for p16 has a diagnostic value only if diffusely and strongly positive, pattern named “block-like”. “Weak and/or focal (w/f) p16 expression” is commonly considered nonspecific. In our previous study, we demonstrated the presence of high-risk HPV (hrHPV) DNA by LiPa method in biopsies showing w/f p16 positivity. The aim of the present study was to investigate the presence of hrHPV-DNA by CISH in the areas showing w/f p16 expression. We assessed the presence of hrHPV16, 18, 31, 33, 51 by CISH in a group of 20 cervical biopsies showing w/f p16 expression, some with increased Ki67, and in 10 cases of block-like expression, employed as control. The immunohistochemical p16 expression was also assessed by digital pathology. hrHPV-CISH nuclear positivity was encountered in 12/20 cases of w/f p16 expression (60%). Different patterns of nuclear positivity were identified, classified as punctate, diffuse and mixed, with different epithelial distributions. Our results, albeit in a limited casuistry, show the presence of HPV in an integrated status highlighted by CISH in w/f p16 positive cases. This could suggest the necessity of a careful follow-up of the patients with “weak” and/or “focal” immunohistochemical patterns of p16, mainly in cases of increased Ki67 cell proliferation index, supplemented with molecular biology examinations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
- Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy.
ORCID-Profile: Daniela Cabibi, Antonino Giulio Giannone, Alberto Quattrocchi, Viviana Benfante, Albert Comelli, Giuseppina Capra
Förderung
- European Union - NextGenerationEU through the Italian Ministry of University and Research under PNRR -M4C2-I1.3 Project PE_00000019 "HEAL ITALIA" to Prof. Dani…
- European Union
Zitieren
APA
Cabibi, D., Giannone, A. G., Quattrocchi, A., Lo Coco, R., Formisano, E., Porcasi, R., Benfante, V., Comelli, A., & Capra, G. (2024). High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105354
Vancouver
Cabibi D, Giannone AG, Quattrocchi A, Lo Coco R, Formisano E, Porcasi R, et al. High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105354
BibTeX
@article{Cabibi2024,
author = {Cabibi, Daniela and Giannone, Antonino Giulio and Quattrocchi, Alberto and Lo Coco, Roberta and Formisano, Eleonora and Porcasi, Rossana and Benfante, Viviana and Comelli, Albert and Capra, Giuseppina},
title = {High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105354}
}
EUVIMED